FDA approved quadrivalent formulation of Fluarix
On Dec. 14, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved GlaxoSmithKline’s quadrivalent formulation…
On Dec. 14, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved GlaxoSmithKline’s quadrivalent formulation…
On Dec. 12, 2012, deCODE genetics announced an agreement whereby Amgen acquired deCODE Genetics, a global leader in…
On Nov. 28, 2012, scientists from the USDA’s Agricultural Research Service (ARS), as part of an international team,…
On Nov. 20, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved first seasonal influenza…
On Nov. 20, 2012, the FDA approved a seasonal flu vaccine produced by Novartis using animal cell culture…
On Nov. 15, 2012, the U.S. Centers for Disease Control and Prevention (CDC) responded to the fungal meningitis…
On Nov. 14, 2012, scientists from the U.S., United Kingdom and Germany announced they had completed the first…
On Nov. 8, 2012, Atossa Genetics, the Breast Health Company completed its IPO with gross proceeds of $4…
On Oct. 24, 2012, the Immunization Practices Advisory Committee (ACIP) voted 14-0 with one abstention to recommend that…
On Oct. 24, 2012, the Immunization Practices Advisory Committee (ACIP) voted to recommend use of HibMenCY (Menhibrix, GlaxoSmithKline),…
On Oct. 4, 2012, Takeda Pharmaceutical and LigoCyte Pharmaceuticals jointly announced that Takeda’s wholly-owned subsidiary, Takeda America Holdings…
On Sept. 28, 2012, the Connecticut Challenge Survivorship Clinic opened at Yale Cancer Center providing — the first…
On Sept. 17, 2012, Oregon Health & Science University (OHSU) in Portland announced that it had received a…
On Sept. 10, 2012, the Albert and Mary Lasker Foundation, which for 67 years has championed the greatest…
On Aug. 30, 2012, a new phlebovirus, discovered in northwestern Missouri by Dr. Scott Folk of Heartland Regional…
On Aug. 10. 2012, Genentech announced that Lucentis (ranibizumab injection) was approved by the U.S. Food and Drug…
On Aug. 3, 2012, GlaxoSmithKline announced that it had completed its acquisition of Human Genome Sciences for US$3.6…
On Jul. 31, 2012, the Connecticut Development Authority (CDA) was merged into Connecticut Innovations (CI) which was created…
On Jul. 26, 2012, the U.S. Centers for Disease Control and Prevention (CDC) responded to a multi-state outbreak…
On Jul. 25, 2012, in a meta-analysis, researchers from the China Medical University in Shenyang and Harvard School…
On Jul. 12, 2012, a decade after declaring its goal of becoming a National Cancer Institute-designated facility, the…
On Jul. 9, 2012, the National Institutes of Health (NIH) announced it had awarded a $65 million five…
On Jul. 9, 2012, the FDA created the “Breakthrough Therapy Designation” that expedites development and review of drugs…
On Jun. 29, 2012, following a competitive renewal process, the National Cancer Institute announced it had awarded the…
On Jun. 26, 2012, Roche announced it had closed the Nutley plant, established in 1929. The Nutley plant…
On Jun. 25, 2012, The St. Louis County Economic Council is opening the doors to its new biotech…
On Jun. 25, 2012, the Rocky Mountain Biological Laboratory (RMBL) announced the unveiling of its Legacy Campaign, a…
On Jun. 24, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved HibMenCY (Menhibrix, GlaxoSmithKline),…
On Jun. 15, 2012, Oxford University researchers announced research from excavations in 2010 on the Black Sea island…
On Jun. 13, 2012, in a project led by the Max Planck Institute for Evolutionary Anthropology in Leipzig,…